Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134.7 EUR | -0.50% |
|
-1.52% | -4.93% |
03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
809B | ||||||
624B | ||||||
289B | ||||||
240B | ||||||
220B |